Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 207

1.

Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.

Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS; Zilver PTX Investigators.

Circ Cardiovasc Interv. 2011 Oct 1;4(5):495-504. doi: 10.1161/CIRCINTERVENTIONS.111.962324. Epub 2011 Sep 27.

PMID:
21953370
[PubMed - indexed for MEDLINE]
Free Article
2.

Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies.

Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O'Leary EE, Tepe G, Scheinert D, Zeller T; Zilver PTX Investigators.

J Am Coll Cardiol. 2013 Jun 18;61(24):2417-27. doi: 10.1016/j.jacc.2013.03.034. Epub 2013 Apr 10. Erratum in: J Am Coll Cardiol. 2013 Aug 13;62(7):666.

PMID:
23583245
[PubMed - indexed for MEDLINE]
Free Article
3.

Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).

Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R, Schoder M.

J Am Coll Cardiol. 2013 Oct 8;62(15):1320-7. doi: 10.1016/j.jacc.2013.05.079. Epub 2013 Jul 10.

PMID:
23831445
[PubMed - indexed for MEDLINE]
4.

Evolving modalities for femoropopliteal interventions.

Ansel GM, Lumsden AB.

J Endovasc Ther. 2009 Apr;16(2 Suppl 2):II82-97. doi: 10.1583/08-2654.1. Review.

PMID:
19624076
[PubMed - indexed for MEDLINE]
5.

Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.

Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators.

Circ Cardiovasc Interv. 2010 Jun 1;3(3):267-76. doi: 10.1161/CIRCINTERVENTIONS.109.903468. Epub 2010 May 18.

PMID:
20484101
[PubMed - indexed for MEDLINE]
Free Article
6.

Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study.

Dake MD, Scheinert D, Tepe G, Tessarek J, Fanelli F, Bosiers M, Ruhlmann C, Kavteladze Z, Lottes AE, Ragheb AO, Zeller T; Zilver PTX Single-Arm Study Investigators.

J Endovasc Ther. 2011 Oct;18(5):613-23. doi: 10.1583/11-3560.1.

PMID:
21992630
[PubMed - indexed for MEDLINE]
7.

Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.

Di Lorenzo E, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G.

Circulation. 2009 Sep 15;120(11):964-72. doi: 10.1161/CIRCULATIONAHA.108.830372. Epub 2009 Aug 31. Retraction in: Circulation. 2010 Mar 2;121(8):e228.

PMID:
19720939
[PubMed - indexed for MEDLINE]
Free Article
8.

Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.

Zeller T, Dake MD, Tepe G, Brechtel K, Noory E, Beschorner U, Kultgen PL, Rastan A.

JACC Cardiovasc Interv. 2013 Mar;6(3):274-81. doi: 10.1016/j.jcin.2012.12.118.

PMID:
23517839
[PubMed - indexed for MEDLINE]
Free Article
9.

Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.

Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G.

Am Heart J. 2009 Oct;158(4):e43-50. doi: 10.1016/j.ahj.2009.03.016.

PMID:
19781402
[PubMed - indexed for MEDLINE]
10.

Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.

Rastan A, Krankenberg H, Baumgartner I, Blessing E, Müller-Hülsbeck S, Pilger E, Scheinert D, Lammer J, Gißler M, Noory E, Neumann FJ, Zeller T.

Circulation. 2013 Jun 25;127(25):2535-41. doi: 10.1161/CIRCULATIONAHA.113.001849. Epub 2013 May 21.

PMID:
23694965
[PubMed - indexed for MEDLINE]
Free Article
11.

The Zilver® PTX® Single Arm Study: 12-month results from the TASC C/D lesion subgroup.

Bosiers M, Peeters P, Tessarek J, Deloose K, Strickler S; Zilver PTX Single-Arm Study Investigators.

J Cardiovasc Surg (Torino). 2013 Feb;54(1):115-22.

PMID:
23296421
[PubMed - indexed for MEDLINE]
12.

PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study.

Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, Lammer J.

J Vasc Interv Radiol. 2001 Jan;12(1):23-31.

PMID:
11200349
[PubMed - indexed for MEDLINE]
13.

Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).

Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.

JACC Cardiovasc Interv. 2013 Dec;6(12):1295-302. doi: 10.1016/j.jcin.2013.07.010. Epub 2013 Nov 13.

PMID:
24239203
[PubMed - in process]
14.

Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.

Gioia G, Benassi A, Mohendra R, Chowdhury K, Masood I, Matthai W.

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):13-20. doi: 10.1002/ccd.21599.

PMID:
18561143
[PubMed - indexed for MEDLINE]
15.

Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).

Hamirani YS, Jibrin I, Abraham D, Merriman B, Wenz C, Bahr RD.

Crit Pathw Cardiol. 2008 Dec;7(4):232-8. doi: 10.1097/HPC.0b013e3181805e0b.

PMID:
19050419
[PubMed - indexed for MEDLINE]
16.

Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?

Antoniou GA, Georgakarakos EI, Antoniou SA, Georgiadis GS.

Interact Cardiovasc Thorac Surg. 2014 Apr 11. [Epub ahead of print]

PMID:
24729201
[PubMed - as supplied by publisher]
Free Article
17.

[PTA versus Palmaz stent placement in femoropopliteal artery stenoses: results of a multicenter prospective randomized study (REFSA)].

Grenacher L, Saam T, Geier A, Müller-Hülsbeck S, Cejna M, Kauffmann GW, Richter GM.

Rofo. 2004 Sep;176(9):1302-10. German.

PMID:
15346266
[PubMed - indexed for MEDLINE]
18.

A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.

Erglis A, Narbute I, Kumsars I, Jegere S, Mintale I, Zakke I, Strazdins U, Saltups A.

J Am Coll Cardiol. 2007 Aug 7;50(6):491-7. Epub 2007 Jul 23.

PMID:
17678730
[PubMed - indexed for MEDLINE]
Free Article
19.

Effectiveness of Zilver PTX eluting stent in TASC C/D lesions and restenosis.

Leopardi M, Houbballah R, Becquemin JP.

J Cardiovasc Surg (Torino). 2014 Apr;55(2):229-34.

PMID:
24670831
[PubMed - indexed for MEDLINE]
20.

Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction.

Gioia G, Matthai W, Benassi A, Rana H, Levite HA, Ewing LG.

Catheter Cardiovasc Interv. 2006 Sep;68(3):392-8.

PMID:
16892436
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk